List view / Grid view
Genomics is the branch of molecular biology concerned with the structure, function, evolution, and mapping of genomes.
Join the international [BC]2 conference and EMBO meeting at BASEL LIFE from 9–12 September: a unique opportunity for today’s scientists to get insights and share the latest discoveries, resources and approaches to make sense of genomic and health-related “big data” for molecular medicine – from precision oncology to infectious diseases.
A new study has used combined therapies to eliminate HIV from mice models, providing potential future cures.
Unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union.
High content data derived for complex immuno-oncology research facilitates a deeper understanding of the tissue microenvironment.
A study has reported that genes delivered to rhesus monkeys are still being expressed four years later.
A new study has identified a key molecule involved in Lyme arthritis which presents options for preventative therapies.
Researchers have presented their new technology for accurately inserting genes into the genome without cutting DNA.
The advent of CRISPR/Cas9 gene editing, together with the plummeting cost of whole-genome sequencing, has cleared a path for the development of customised cancer cell models. Here, we discuss recent developments in the field and challenges associated with targeted-therapy resistance.
Sartorius Cubis® II is designed to follow US FDA data integrity principles that require data to be accurate, legible, contemporaneous, original and attributable.
A study of almost half a million people links a mutation that protects against HIV infection to an earlier death.
A recent study has uncovered a key mechanism that allows some of the world's deadliest viruses to replicate.
In a recent study more than half of patients with advanced prostate cancers appear to be strong candidates for targeted cancer therapies.
A new study analysing both the entire set of genes and all the proteins produced by colon cancer tissues has revealed a more comprehensive view of the tumour.
Building on previous research, scientists have made improvements to an artificial intelligence pipeline used to diagnose genetic diseases via blood samples obtained from gravely ill infants.
